These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8454851)

  • 1. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo.
    Sato TA; Widmer MB; Finkelman FD; Madani H; Jacobs CA; Grabstein KH; Maliszewski CR
    J Immunol; 1993 Apr; 150(7):2717-23. PubMed ID: 8454851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor.
    Fanslow WC; Clifford KN; Park LS; Rubin AS; Voice RF; Beckmann MP; Widmer MB
    J Immunol; 1991 Jul; 147(2):535-40. PubMed ID: 1830065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4.
    Chilton PM; Fernandez-Botran R
    J Immunol; 1993 Dec; 151(11):5907-17. PubMed ID: 8245438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset.
    Fernandez-Botran R; Chilton PM; Ma Y; Windsor JL; Street NE
    Cytokine; 1997 Mar; 9(3):166-77. PubMed ID: 9126705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro.
    Maliszewski CR; Sato TA; Vanden Bos T; Waugh S; Dower SK; Slack J; Beckmann MP; Grabstein KH
    J Immunol; 1990 Apr; 144(8):3028-33. PubMed ID: 2139075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 requirements for the generation of secondary in vivo IgE responses.
    Katona IM; Urban JF; Kang SS; Paul WE; Finkelman FD
    J Immunol; 1991 Jun; 146(12):4215-21. PubMed ID: 1674956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4.
    Ma Y; Hurst HE; Fernandez-Botran R
    J Pharmacol Exp Ther; 1996 Oct; 279(1):340-50. PubMed ID: 8859012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes.
    Finkelman FD; Madden KB; Morris SC; Holmes JM; Boiani N; Katona IM; Maliszewski CR
    J Immunol; 1993 Aug; 151(3):1235-44. PubMed ID: 8393043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor.
    Blum H; Wolf M; Enssle K; Röllinghoff M; Gessner A
    J Immunol; 1996 Sep; 157(5):1846-53. PubMed ID: 8757301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).
    König B; Fischer A; König W
    Immunology; 1995 Aug; 85(4):604-10. PubMed ID: 7558156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.
    Morris SC; Coffman RL; Finkelman FD
    J Immunol; 1998 Apr; 160(7):3299-304. PubMed ID: 9531287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis.
    Fernandez-Botran R; Wynn TA; Hieny S; Caspar P; Chilton PM; Sher A
    Eur J Immunol; 1995 Mar; 25(3):649-56. PubMed ID: 7705393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases.
    Nasert S; Millner M; Herz U; Lack G; Wahn U; Gelfand EW; Renz H
    Behring Inst Mitt; 1995 Jun; (96):118-30. PubMed ID: 7575347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the expression of the soluble and membrane forms of the murine IL-4 receptor.
    Chilton PM; Fernandez-Botran R
    Cell Immunol; 1997 Sep; 180(2):104-15. PubMed ID: 9341740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo biological effects of recombinant soluble interleukin-4 receptor.
    Maliszewski CR; Sato TA; Davison B; Jacobs CA; Finkelman FD; Fanslow WC
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):233-7. PubMed ID: 8016157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
    Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
    J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice.
    Kobayashi H; Kobayashi M; Utsunomiya T; Herndon DN; Pollard RB; Suzuki F
    J Immunol; 1999 Jun; 162(12):7148-54. PubMed ID: 10358160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A soluble form of IL-13 receptor alpha 1 promotes IgG2a and IgG2b production by murine germinal center B cells.
    Poudrier J; Graber P; Herren S; Gretener D; Elson G; Berney C; Gauchat JF; Kosco-Vilbois MH
    J Immunol; 1999 Aug; 163(3):1153-61. PubMed ID: 10415009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline and productive C epsilon gene expression during in vivo IgE responses.
    Thyphronitis G; Katona IM; Gause WC; Finkelman FD
    J Immunol; 1993 Oct; 151(8):4128-36. PubMed ID: 8409390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG.
    Peçanha LM; Yamaguchi H; Lees A; Noelle RJ; Mond JJ; Snapper CM
    J Immunol; 1993 Mar; 150(6):2160-8. PubMed ID: 7680684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.